Marion Thibaudin

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Top Venues

Cancer immunology, immunotherapy : CII

Nature medicine

Genes and immunity

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Marion Thibaudin, Jean-David Fumet, Benoist Chibaudel, Jaafar Bennouna, Christophe Borg, Jerome Martin-Babau, Romain Cohen, Marianne Fonck, Julien Taieb, Emeric Limagne, Julie Blanc, Elise Ballot, Léa Hampe, Marjorie Bon, Susy Daumoine, Morgane Peroz, Hugo Mananet, Valentin Derangère, Romain Boidot, Henri-Alexandre Michaud, Caroline Laheurte, Olivier Adotevi, Aurélie Bertaut, Caroline Truntzer, François Ghiringhelli
First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial. Nature medicine (2023)
François Ghiringhelli, Marion Thibaudin
Targeting CTLA-4: a possible solution for microsatellite-stable colorectal cancer. Genes and immunity (2023)
Marion Thibaudin, Emeric Limagne, Léa Hampe, Elise Ballot, Caroline Truntzer, Francois Ghiringhelli
Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer. Cancer immunology, immunotherapy : CII 71 (10) (2022)
Romain Mary, Fanny Chalmin, Théo Accogli, Mélanie Bruchard, Christophe Hibos, Joséphine Melin, Caroline Truntzer, Emeric Limagne, Valentin Derangere, Marion Thibaudin, Etienne Humblin, Romain Boidot, Sandrine Chevrier, Laurent Arnould, Corentin Richard, Quentin Klopfenstein, Antoine Bernard, Yoshihiro Urade, James A Harker, Lionel Apetoh, François Ghiringhelli, Frédérique Végran
Hematopoietic Prostaglandin D2 Synthase Controls Tfh/Th2 Communication and Limits Tfh Antitumor Effects. Cancer immunology research 10 (7) (2022)